306 Predictors of immunotherapy benefit in Merkel cell carcinoma
Abstract
Background
Merkel cell carcinoma is a rare cancer for which the standard-of-care is immune checkpoint blockade in the recurrent/metastatic setting. However, immunotherapy is not effective in all patients. A greater understanding of molecular mechanisms and potential predictive biomarkers are unmet needs for clinicians and researchers.Methods
We undertook a retrospective analysis of 45 patients treated at our institution from...Paper Details
Title
306 Predictors of immunotherapy benefit in Merkel cell carcinoma
Published Date
Nov 1, 2020
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History